This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Listen to this podcast in New York Times Audio, our new iOS app for news subscribers. Download now at nytimes.com/audioapp
…
continue reading
Content provided by Audioboom and Not So Different: a Podcast from The Center for Biosimilars. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Not So Different: a Podcast from The Center for Biosimilars or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
S5 Ep12: Biosimilars Regulatory Roundup for November 2022—Podcast Edition
MP3•Episode home
Manage episode 348900991 series 2161808
Content provided by Audioboom and Not So Different: a Podcast from The Center for Biosimilars. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Not So Different: a Podcast from The Center for Biosimilars or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Show notes
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
155 episodes
MP3•Episode home
Manage episode 348900991 series 2161808
Content provided by Audioboom and Not So Different: a Podcast from The Center for Biosimilars. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Not So Different: a Podcast from The Center for Biosimilars or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Show notes
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
155 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.